KDR and cervical cancer: Collectively, the potency in MCF-7, robust VEGFR-2 and p38α MAPK modulation, and coherent computational validation position compound 16 as a promising fluorinated coumarin hybrid for multitarget therapy in breast and cervical cancers, warranting in vivo evaluation and pharmacokinetic studies to assess translational potential.